| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1002/1097-0142(19940801)74:3+<1006::AID-CNCR2820741506>3.0.CO;2-V |
| P698 | PubMed publication ID | 7913661 |
| P2093 | author name string | Siegall CB | |
| P2860 | cites work | Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues | Q35994177 |
| P433 | issue | 3 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1006-1012 | |
| P577 | publication date | 1994-08-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Targeted toxins as anticancer agents | |
| P478 | volume | 74 |
| Q42518327 | A monoclonal antibody KIS-1 recognizing a new membrane antigen on human squamous-cell carcinoma |
| Q38560509 | Advanced and controlled drug delivery systems in clinical disease management |
| Q34038801 | Development of dendritic-cell based prostate cancer vaccine |
| Q38108516 | Diphtheria toxin-based targeted toxin therapy for brain tumors |
| Q73207851 | Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs |
| Q41264943 | Epitopes for human CD4+ cells on diphtheria toxin: structural features of sequence segments forming epitopes recognized by most subjects |
| Q41442987 | Growth factors in bladder cancer |
| Q40380727 | Immunoconjugates and immunotoxins for therapy of carcinomas. |
| Q35210454 | Immunotoxin therapy for CNS tumor |
| Q41124112 | Immunotoxin therapy. |
| Q73209036 | Intra-tumoral application of a heregulin-exotoxin-a fusion protein causes rapid tumor regression without adverse systemic or local effects |
| Q33807301 | Progress in active specific immunotherapy of prostate cancer |
| Q36811133 | Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy. |
| Q72013272 | Superantigen-staphylococal-enterotoxin-A-dependent and antibody-targeted lysis of GD2-positive neuroblastoma cells |
| Q37954275 | Targeted toxins in brain tumor therapy |
| Q35597943 | Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme |
| Q27006226 | Toxin-based targeted therapy for malignant brain tumors |
| Q24813585 | Treatment of solid tumors with immunotoxins |
| Q40433289 | Tumor Therapy by Immune Recruitment with Bispecific Antibodies |
Search more.